Issues in the pharmacokinetics of trichloroethylene and its metabolites.
about
Human health effects of trichloroethylene: key findings and scientific issuesThe trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine but not trichloroacetate inhibits pathogen-stimulated TNF-α in human extraplacental membranes in vitroComparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: kidney effects.Trichloroethylene cancer epidemiology: a consideration of select issues.Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesisKey scientific issues in the health risk assessment of trichloroethyleneChloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans.Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.Liquid chromatography electrospray ionization tandem mass spectrometry analysis method for simultaneous detection of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.Trichloroethylene risk assessment: a review and commentary.Toxicological effects of trichloroethylene exposure on immune disorders.Comments on "Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL+/- mice.
P2860
Q26825606-F33FB76B-F5C0-48C2-A79D-DF34CBB71ACAQ28393746-5F2DE678-EDD9-4F22-952A-D12737D2170DQ34802950-84D4D25A-572B-48A3-B5F4-840F90F57E54Q35039229-760A3E6A-6E39-468F-8574-4B7372B0C9BBQ35039264-C4574BBE-E963-40F4-89EA-A14564A5523CQ35039295-B96DE8C4-2AFB-4DF5-9064-A3D8A7579CEFQ35684236-A84A0346-E595-43EF-8D76-23B3EE39EA8CQ37333030-B53A6093-BC8E-4986-A89E-7F907BE454EFQ37396395-71C33782-89F2-431B-8C13-6A1FFD9D9C0CQ37620349-11FC4588-49B2-4622-8897-F2737CC12883Q38638908-80940624-189A-40A6-BB80-53598CA78E8AQ46196640-50DFB9D4-F811-4932-B1FF-89244D8FC139
P2860
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@ast
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@en
type
label
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@ast
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@en
prefLabel
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@ast
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@en
P2093
P2860
P356
P1476
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
@en
P2093
John C Lipscomb
Marina V Evans
Miles S Okino
Weihsueh A Chiu
P2860
P304
P356
10.1289/EHP.8691
P5008
P577
2006-09-01T00:00:00Z